The use of topical capsaicin in managing arthritis pain: A clinician's perspective

https://doi.org/10.1016/S0049-0172(10)80026-5Get rights and content

Effective management of pain and maintenance of functional status are issues common to all forms of arthritis. The rationale for the use of topical capsaicin toward achieving this goal is reviewed from a clinician's perspective. In addition to presenting findings from the clinical literature, clinical experience has been considered in addressing issues such as patient selection, dosage, systemic side effects, cost of therapy, and patient education.

References (23)

  • GE Dailey et al.

    Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy

    Diabetes Care

    (1992)
  • P Donofrio et al.

    Treatment of painful diabetic neuropathy with topical capsaicin: A multi-center, double-blind, vehicle-controlled study

    Arch Intern Med

    (1991)
  • NM Scheffler et al.

    Treatment of painful diabetic neuropathy with capsaicin 0.075%

    J APMA

    (1991)
  • R Tandan et al.

    Topical capsaicin in painful diabetic neuropathy: Controlled study with long-term follow-up

    Diabetes Care

    (1992)
  • R Tandan et al.

    Topical capsaicin in painful diabetic neuropathy: Effect on sensory function

    Diabetes Care

    (1992)
  • JE Bernstein et al.

    Topical capsaicin treatment of chronic postherpetic neuralgia

    J Am Acad Dermatol

    (1989)
  • A Peikert et al.

    Topical 0.025% capsaicin in chronic post-herpetic neuralgia: Efficacy, predictors of response and long-term course

    J Neurol

    (1991)
  • CPN Watson et al.

    Post-herpetic neuralgia and topical capsaicin

    Pain

    (1988)
  • CPN Watson et al.

    A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia

    Clin Ther

    (1993)
  • CPN Watson et al.

    The postmastectomy pain syndrome and topical capsaicin: A randomized trial

    Pain

    (1992)
  • WP Cheshire et al.

    Treatment of reflex sympathetic dystrophy with topical capsaicin: Case report

    Pain

    (1990)
  • Cited by (9)

    • Topical Analgesics

      2009, Perioperative Nursing Clinics
      Citation Excerpt :

      PHN,39–41 chronic distal painful polyneuropathy,42 oral neuropathic pain,43 surgical neuropathic pain,44 and the pain associated with Guillain-Barré syndrome.45 In the treatment of non-neuropathic pain, capsaicin has a role, with evidence of a pain-relieving effect in osteoarthritis,46–51 and neck pain.52 It appears that capsaicin achieves its pain-relieving effect by reversibly depleting sensory nerve endings of substance P53,54 and by reducing the density of epidermal nerve fibers, also in a reversible fashion.55

    • Topical analgesic agents

      2009, Current Therapy in Pain
    • Topical Analgesic Agents

      2008, Clinics in Geriatric Medicine
      Citation Excerpt :

      It is available commercially as a 0.025% and a 0.075% cream. It reduces the pain of diabetic neuropathy [19–22], postherpetic neuralgia [23–25], surgical neuropathic pain [26], chronic distal painful polyneuropathy [27], osteoarthritis [28–33], and neck pain [34]. In practice, repeated application of capsaicin is required before clinical effect may be apparent.

    • Topical Analgesics

      2007, Anesthesiology Clinics
      Citation Excerpt :

      It has now been shown to reduce the pain associated with painful diabetic neuropathy [35–38], PHN [39–41], chronic distal painful polyneuropathy [42], oral neuropathic pain [43], surgical neuropathic pain [44], and the pain associated with Guillain-Barré syndrome [45]. In the treatment of non-neuropathic pain, capsaicin has a role, with evidence of a pain-relieving effect in osteoarthritis [46–51] and neck pain [52]. It appears that capsaicin achieves its pain-relieving effect by reversibly depleting sensory nerve endings of substance P [53,54] and by reducing the density of epidermal nerve fibers, also in a reversible fashion [55].

    • Topical Analgesics

      2007, Medical Clinics of North America
      Citation Excerpt :

      It has now been shown to reduce the pain associated with painful diabetic neuropathy [35–38], PHN [39–41], chronic distal painful polyneuropathy [42], oral neuropathic pain [43], surgical neuropathic pain [44], and the pain associated with Guillain-Barré syndrome [45]. In the treatment of non-neuropathic pain, capsaicin has a role, with evidence of a pain-relieving effect in osteoarthritis [46–51] and neck pain [52]. It appears that capsaicin achieves its pain-relieving effect by reversibly depleting sensory nerve endings of substance P [53,54] and by reducing the density of epidermal nerve fibers, also in a reversible fashion [55].

    View all citing articles on Scopus

    Supported by Genderm Corporation, Lincolnshire, IL, and Knoll Pharmaceutical Company, Whippany, NJ.

    View full text